Alnylam Pharmaceuticals (ALNY) Assets (2009 - 2026)
Alnylam Pharmaceuticals' Assets came in at $5.56 billion for Q2 2026, up 21.7% from $4.57 billion a year earlier and up 8.4% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals' Assets was $4.97 billion, up 17.1% from FY2024.
- Assets has increased in each of the last three years, with a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- Going back by year, Assets was $4.24 billion in FY2024 (+10.7%), $3.83 billion in FY2023 (+8.0%), $3.55 billion in FY2022 (-2.7%) and $3.64 billion in FY2021 (+6.9%).
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2009.
- Year-over-year, Assets has increased for 13 consecutive quarters, with growth averaging 15.0% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q2 2026 (growth of 21.7%), and the weakest in Q2 2022 (a decline of 5.1%).
- Business Quant data shows ALNY's Assets at $5.13 billion (Q1 2026), $4.97 billion (Q4 2025) and $4.85 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 5.56 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.56 Bn |
| Mar 31, 2026 | 5.13 Bn |
| Dec 31, 2025 | 4.97 Bn |
| Sep 30, 2025 | 4.85 Bn |
| Jun 30, 2025 | 4.57 Bn |
| Mar 31, 2025 | 4.21 Bn |
| Dec 31, 2024 | 4.24 Bn |
| Sep 30, 2024 | 4.21 Bn |
| Jun 30, 2024 | 4.01 Bn |
| Mar 31, 2024 | 3.82 Bn |
| Dec 31, 2023 | 3.83 Bn |
| Sep 30, 2023 | 3.84 Bn |
| Jun 30, 2023 | 3.40 Bn |
| Mar 31, 2023 | 3.39 Bn |
| Dec 31, 2022 | 3.55 Bn |
| Sep 30, 2022 | 3.54 Bn |
| Jun 30, 2022 | 3.33 Bn |
| Mar 31, 2022 | 3.43 Bn |
| Dec 31, 2021 | 3.64 Bn |
| Sep 30, 2021 | 3.47 Bn |
API Access
Alnylam Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();